Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study

Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis

Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,779 · see citing works

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700 · see citing works

Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial.

Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183 · see citing works

Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections

Schüetz, P., Christ‐Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Suter‐Widmer, I., Neidert, S., Fricker, T., Blum, C. A., Schild, U., et al. (2009) · JAMA · doi:10.1001/jama.2009.1297 · Cited by 947 · see citing works

Insights into the Interaction between Influenza Virus and Pneumococcus

McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846 · see citing works

Procalcitonin increase in early identification of critically ill patients at high risk of mortality*

Jensen, J. S., Heslet, L., Jensen, T. H., Espersen, K., Steffensen, P., & Tvede, M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239116.01855.61 · Cited by 380 · see citing works

Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza

Palacios, G., Hornig, M., Cisterna, D., Savji, N., Bussetti, A. V., Kapoor, V., Hui, J., Tokarz, R., Briese, T., Baumeister, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008540 · Cited by 275 · see citing works

Measurement of Procalcitonin Levels in Children with Bacterial or Viral Meningitis

Gendrel, D., Raymond, J., Assicot, M., Moulin, F., Iniguez, J., Lebon, P., & Bohuon, C. (1997) · Clinical Infectious Diseases · doi:10.1086/513633 · Cited by 270 · see citing works

Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators

Christ‐Crain, M., & Müller, B. (2007) · European Respiratory Journal · doi:10.1183/09031936.00166106 · Cited by 254 · see citing works

Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children

Toikka, P., Irjala, K. M. A., Juvén, T., Virkki, R., Mertsola, J., Leinonen, M., & Ruuskanen, O. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200007000-00003 · Cited by 252 · see citing works

Influenza Circulation and the Burden of Invasive Pneumococcal Pneumonia during a Non‐pandemic Period in the United States

Walter, N. D., Taylor, T. H., Shay, D. K., Thompson, W., Brammer, L., Dowell, S. F., & Moore, M. R. (2009) · Clinical Infectious Diseases · doi:10.1086/649208 · Cited by 105 · see citing works

Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection

Ingram, P. R., Inglis, T. J. J., Moxon, D., & Speers, D. J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1746-3 · Cited by 102 · see citing works

The Use of Antimicrobial Agents after Diagnosis of Viral Respiratory Tract Infections in Hospitalized Adults: Antibiotics or Anxiolytics?

Shiley, K. T., Lautenbach, E., & Lee, I. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/656596 · Cited by 67 · see citing works

Prognostic value of procalcitonin in Legionella pneumonia

Haeuptle, J., Zaborsky, R., Fiumefreddo, R., Trampuž, A., Steffen, I., Frei, R., Christ‐Crain, M., Müller-Stich, B. P., & Schüetz, P. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0592-5 · Cited by 67 · see citing works

Procalcitonin in severe acute respiratory syndrome (SARS)

Chua, A. P., & Lee, K. H. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.01.015 · Cited by 30 · see citing works

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192 · see citing works

The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis.

Klein, E. Y., Monteforte, B., Gupta, A., Jiang, W., May, L., Hsieh, Y., & Dugas, A. (2016) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12398 · Cited by 574 · see citing works

New Approaches to Sepsis: Molecular Diagnostics and Biomarkers

Reinhart, K., Bauer, M. W., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 528 · see citing works

The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09.

MacIntyre, C. R., Chughtai, A. A., Barnes, M., Ridda, I., Seale, H., Toms, R., & Heywood, A. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3548-0 · Cited by 323 · see citing works

Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU

Contou, D., Claudinon, A., Pajot, O., Micaëlo, M., Flandre, P. L., Dubert, M., Cally, R., Logre, E., Fraissé, M., Mentec, H., et al. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00736-x · Cited by 324 · see citing works

Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis

Kamat, I., Ramachandran, V., Eswaran, H., Guffey, D., & Musher, D. M. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz545 · Cited by 273 · see citing works

Bacterial and viral infections associated with influenza

Joseph, C., Togawa, Y., & Shindo, N. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12089 · Cited by 250 · see citing works

Clinical Utility and Measurement of Procalcitonin.

Samsudin, I. N., & Vasikaran, S. D. (2017) · Europe PMC (PubMed Central) · Cited by 215 · see citing works

Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review

Kapasi, A. J., Dittrich, S., González, I. J., & Rodwell, T. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160278 · Cited by 164 · see citing works

Role of procalcitonin use in the management of sepsis

Gregoriano, C., Heilmann, E., Molitor, A., & Schüetz, P. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.11.63 · Cited by 170 · see citing works

Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis

Rodríguez, A. H., Avilés‐Jurado, F. X., Díaz, E., Schüetz, P., Trefler, S., Solé‐Violán, J., Cordero, L., Vidaur, L., Estella, Á., Pozo, J. C., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.11.007 · Cited by 136 · see citing works

Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis

Pfister, R., Kochanek, M., Leygeber, T., Brun‐Buisson, C., Cuquemelle, É., Machado, M. P., Piacentini, E. A., Hammond, N. E., Ingram, P. R., & Michels, G. (2014) · Critical Care · doi:10.1186/cc13760 · Cited by 105 · see citing works

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

Albrich, W. C., & Harbarth, S. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3978-8 · Cited by 96 · see citing works

Role of Procalcitonin in Managing Adult Patients With Respiratory Tract Infections

Schüetz, P., Amin, D., & Greenwald, J. L. (2012) · CHEST Journal · doi:10.1378/chest.11-2430 · Cited by 94 · see citing works

Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia

Gautam, S., Cohen, A. J., Stahl, Y., Toro, P. V., Young, G. M., Datta, R., Yan, X., Ristic, N., Bermejo, S. D., Sharma, L., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-214896 · Cited by 91 · see citing works

Staphylococcus aureus Pneumonia in the Community

He, H., & Wunderink, R. G. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1709992 · Cited by 88 · see citing works

Promising New Assays and Technologies for the Diagnosis and Management of Infectious Diseases

Mitsuma, S., Mansour, M. K., Dekker, J. P., Kim, J., Rahman, M. Z., Tweed-Kent, A., & Schüetz, P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis1014 · Cited by 82 · see citing works

Sepsis: From Pathophysiology to Individualized Patient Care

László, I., Trásy, D., Molnár, Z., & Fazakas, J. (2015) · Journal of Immunology Research · doi:10.1155/2015/510436 · Cited by 83 · see citing works

Biomarker-guided personalised emergency medicine for all – hope for another hype?

Schüetz, P., Aujesky, D., Mueller, C. E., & Müller-Stich, B. P. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14079 · Cited by 81 · see citing works

PaCO2 and alveolar dead space are more relevant than PaO2/FiO2 ratio in monitoring the respiratory response to prone position in ARDS patients: a physiological study

Charron, C., Repessé, X., Bouferrache, K., Bodson, L., Castro, S., Page, B., Jardin, F., & Vieillard‐Baron, A. (2011) · Critical Care · doi:10.1186/cc10324 · Cited by 71 · see citing works

The role of human metapneumovirus in the critically ill adult patient

Hasvold, J., Sjoding, M. W., Pohl, K., Cooke, C. R., & Hyzy, R. C. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.09.035 · Cited by 70 · see citing works

CD169 and CD64 could help differentiate bacterial from CoVID ‐19 or other viral infections in the Emergency Department

Bourgoin, P., Soliveres, T., Barbaresi, A., Loundou, A., Belkacem, I. A., Arnoux, I., Bernot, D., Loosveld, M., Morange, P., Michelet, P., et al. (2021) · Cytometry Part A · doi:10.1002/cyto.a.24314 · Cited by 52 · see citing works

Recomendaciones del Grupo de Trabajo Enfermedades Infecciosas (GTEI) de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) y el Grupo de Estudio de Infecciones en el Paciente Crítico (GEIPC) de la Sociedad Española de Enfermedades Infecciosas y Microbiología clínica (SEIMC) para el diagnóstico y tratamiento de la gripe A/H1N1 en pacientes adultos graves hospitalizados en las Unidades de Cuidados Intensivos

Rodríguez, A. H., Álvarez-Rocha, L., Sirvent, J. M., Zaragoza, R., Nieto, M., Arenzana, Á., Luque, P., Socías, L., Martín, M., Navarro, D., et al. (2012) · Medicina Intensiva · doi:10.1016/j.medin.2011.11.020 · Cited by 52 · see citing works

Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics

Mason, C. Y., Kanitkar, T., Richardson, C., Lanzman, M., Stone, Z., Mahungu, T. W., Mack, D. J. F., Wey, E. Q., Lamb, L., Balakrishnan, I., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa563 · Cited by 47 · see citing works

Clinical utility of procalcitonin and its association with pathogenic microorganisms

Xu, H., Tian, M., & Pan, S. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1988047 · Cited by 47 · see citing works

Polymicrobial community‐acquired pneumonia: An emerging entity

Cillóniz, C., Čivljak, R., Nicolini, A., & Torres, A. (2015) · Respirology · doi:10.1111/resp.12663 · Cited by 45 · see citing works

Biomarkers of Infection: Are They Useful in the ICU?

Heilmann, E., Gregoriano, C., & Schüetz, P. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1696689 · Cited by 44 · see citing works

Inflammatory response in mixed viral-bacterial community-acquired pneumonia

Bello, S., Mincholé, E., Fandos, S., Lasierra, A., Ruiz, M. A., Simon, A. L., Panadero, C., Lapresta, C., Menéndez, R., & Torres, A. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-123 · Cited by 42 · see citing works

Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation

Antonelli, M. M., Bonten, M. J. M., Chastre, J. E., Citerio, G., Conti, G., Curtis, J. R., Backer, D. D., Hedenstierna, G., Joannidis, M., Macrae, D. J., et al. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2467-6 · Cited by 42 · see citing works

Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis

Wu, M.-H., Lin, C.-C., Huang, S.-L., Shih, H.-M., Wang, C., Lee, C., & Wu, J.-Y. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2012.00386.x · Cited by 41 · see citing works

Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011–2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance

Hong, K., Cheong, H. J., Choi, W. S., Lee, J., Wie, S., Baek, J. H., Kim, H. Y., Jeong, H. W., & Kim, W. J. (2013) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2013.07.001 · Cited by 38 · see citing works

Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial CoinfectionPreprint

Wei, W., Ortwine, J. K., Mang, N. S., Joseph, C., Hall, B. C., & Prokesch, B. C. (2020) · medRxiv · doi:10.1101/2020.06.16.20133181 · Cited by 42 · see citing works

Personalized medicine in severe influenza

Valenzuela-Sánchez, F., Valenzuela-Méndez, B., Gutiérrez, J. F. R., & Rello, J. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2611-2 · Cited by 37 · see citing works

Biomarkers for Sepsis: A Review with Special Attention to India

Nelson, G. E., Mave, V., & Gupta, A. (2014) · BioMed Research International · doi:10.1155/2014/264351 · Cited by 37 · see citing works

Severe flu management: a point of view

Torres, A., Loeches, I.-M., Sligl, W., & Lee, N. L. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05868-8 · Cited by 36 · see citing works

Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit

Rodríguez, A. H., Álvarez-Rocha, L., Sirvent, J. M., Zaragoza, R., Nieto, M., Arenzana, Á., Luque, P., Socías, L., Martín, M., Navarro, D., et al. (2012) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2012.03.002 · Cited by 37 · see citing works

Viral–bacterial interactions–therapeutic implications

Deng, J. C. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12174 · Cited by 37 · see citing works

Utilidad y valor pronóstico de los biomarcadores en los pacientes con neumonía adquirida en la comunidad en los servicios de urgencias

Julián-Jiménez, A., del Castillo, J. M. G., & Candel, F. J. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.02.024 · Cited by 34 · see citing works

Pulmonary complications of influenza infection: a targeted narrative review

Daoud, A., Laktineh, A., Macrander, C., Mushtaq, A., & Soubani, A. O. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1592400 · Cited by 33 · see citing works

Ability of Procalcitonin to Discriminate Infection from Non-Infective Inflammation Using Two Pleural Disease Settings

McCann, F. J., Chapman, S. J., Yu, W. C., Maskell, N. A., Davies, R. J. O., & Lee, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049894 · Cited by 31 · see citing works

Determining best outcomes from community‐acquired pneumonia and how to achieve them

Hadfield, J., & Bennett, L. (2017) · Respirology · doi:10.1111/resp.13218 · Cited by 30 · see citing works

Clinical Research Assessment By Flow Cytometry of Biomarkers for Infectious Stratification in An Emergency Department

Bourgoin, P., Soliveres, T., Ahriz, D., Arnoux, I., Meisel, C., Unterwalder, N., Morange, P., Michelet, P., Malergue, F., & Markarian, T. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0214 · Cited by 28 · see citing works

Co-infection with influenza-associated acute respiratory distress syndrome requiring extracorporeal membrane oxygenation

Rozencwajg, S., Bréchot, N., Schmidt, M., Hékimian, G., Lebreton, G., Besset, S., Franchineau, G., Nieszkowska, A., Leprince, P. N., Combes, A., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.11.005 · Cited by 26 · see citing works

Procalcitonin and sepsis: recent data on diagnostic utility prognostic potential and therapeutic implications in critically ill patients.

Kopterides, P., & Tsangaris, I. (2012) · PubMed · Cited by 25 · see citing works

The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults

Carbonell, R., Moreno, G., Martín‐Loeches, I., Bodí, M. A., & Rodríguez, A. H. (2023) · Antibiotics · doi:10.3390/antibiotics12010161 · Cited by 24 · see citing works

Combination of procalcitonin and C‐reactive protein levels in the early diagnosis of bacterial co‐infections in children with H1N1 influenza

Li, Z., He, L., Li, S., He, W., Zha, C., Ou, W., Hou, Q., Wang, W., Sun, X., & Liang, H. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12621 · Cited by 23 · see citing works

Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care?

Schüetz, P., Haubitz, S., & Müeller, B. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328354b2c8 · Cited by 23 · see citing works

Procalcitonin as Biomarker of Infection: Implications for Evaluation and Treatment

Gonçalves, P. F., Falcão, L. M., & Pinheiro, I. D. (2015) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000210 · Cited by 21 · see citing works

The role of procalcitonin as a guide for the diagnosis, prognosis, and decision of antibiotic therapy for lower respiratory tract infections

Sadon, A. A.-A., Hamdy, G., Saraya, M. A., Fawzy, E., Anwar, E., & Abdulattif, S. (2013) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2013.07.017 · Cited by 20 · see citing works

Flow Cytometry Evaluation of Infection-Related Biomarkers in Febrile Subjects in the Emergency Department

Bourgoin, P., Lediagon, G., Arnoux, I., Bernot, D., Morange, P., Michelet, P., Malergue, F., & Markarian, T. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0256 · Cited by 20 · see citing works

Usefulness and prognostic value of biomarkers in patients with community-acquired pneumonia in the emergency department

Julián-Jiménez, A., del Castillo, J. M. G., & Candel, F. J. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2017.04.033 · Cited by 19 · see citing works

Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

Voiriot, G., Fartoukh, M. S., Durand‐Zaleski, I., Berard, L., Rousseau, A., Armand-Lefèvre, L., Verdet, C., Argaud, L., Klouche, K., Mégarbane, B., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048187 · Cited by 18 · see citing works

Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?

Chen, Z., Zhan, Q., Huang, L., & Wang, C. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1195048 · Cited by 17 · see citing works

Interest of a simple on-line screening registry for measuring ICU burden related to an influenza pandemic

Richard, J.-C., Pham, T. O., Brun‐Buisson, C., Reignier, J., Mercat, A., Beduneau, G., Regnier, B., Mourvillier, B., Guitton, C., Castanier, M., et al. (2012) · Critical Care · doi:10.1186/cc11412 · Cited by 17 · see citing works

Bacterial coinfection is associated with severity of avian influenza A (H7N9), and procalcitonin is a useful marker for early diagnosis

Yang, M., Gao, H., Chen, J., Xu, X., Tang, L., Yang, Y., Liang, W., Yu, L., Sheng, J., & Li, L. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.10.018 · Cited by 17 · see citing works

Severe acute respiratory infections in the postpandemic era of H1N1

Poulakou, G., Pérez-Carrasco, M., & Rello, J. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32835605f2 · Cited by 14 · see citing works

The behavior and diagnostic utility of procalcitonin and five other inflammatory molecules in critically ill patients with respiratory distress and suspected 2009 influenza a H1N1 infection

Paiva, M. B. S., Botoni, F. A., Teixeira, A. L., de Miranda, A. S., de Oliveira, C. R. A., Abrahão, J. D. O., Faria, G. M., & Junior, V. A. N. (2012) · Clinics · doi:10.6061/clinics/2012(04)05 · Cited by 14 · see citing works

Obesity and pro-inflammatory mediators are associated with acute kidney injury in patients with A/H1N1 influenza and acute respiratory distress syndrome

Cruz‐Lagunas, A., Jiménez-Álvarez, L. A., Ramírez, G. A., Mendoza-Milla, C., García-Sancho, M. C., Ávila‐Moreno, F., Zamudio, P., Urrea, F., Ortíz-Quintero, B., Campos-Toscuento, V. L., et al. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.10.006 · Cited by 13 · see citing works

C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections

Duan, S., Gu, X., Fan, G., Zhou, F., Zhu, G., & Cao, B. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01672-7 · Cited by 12 · see citing works

Plasma Levels of Mid-Regional Proadrenomedullin Accurately Identify H1N1pdm09 Influenza Virus Patients with Risk of Intensive Care Admission and Mortality in the Emergency Department

Valenzuela-Méndez, B., Valenzuela-Sánchez, F., Gutiérrez, J. F. R., Bohollo-de-Austria, R. Á., Estella, Á., Martínez-García, P., González-García, M. Á., & Rello, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010084 · Cited by 12 · see citing works

Latest developments in early diagnosis and specific treatment of severe influenza infection

Valenzuela-Sánchez, F., Valenzuela-Méndez, B., Gutiérrez, J. F. R., & Estella, Á. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.09.006 · Cited by 11 · see citing works

Biomarkers: Are They Useful in Severe Community-Acquired Pneumonia?

Póvoa, P. M. S. R., Pitrowsky, M. T., Guerreiro, G., Pacheco, M. B., & Salluh, J. I. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1777771 · Cited by 11 · see citing works

Bacterial Community- and Hospital-Acquired Pneumonia in Patients with Critical COVID-19—A Prospective Monocentric Cohort Study

Doubravská, L., Sedláková, M. H., Fišerová, K., Klementová, O., Turek, R., Langová, K., & Kolář, M. (2024) · Antibiotics · doi:10.3390/antibiotics13020192 · Cited by 11 · see citing works

Inflammatory Biomarkers Are Inaccurate Indicators of Bacterial Infection on Admission in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease—A Systematic Review and Diagnostic Accuracy Network Meta-Analysis

Pázmány, P., Soós, A., Hegyi, P. J., Dohos, D., Kiss, S., Szakács, Z., Párniczky, A., Garami, A., Péterfi, Z., & Molnár, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.639794 · Cited by 10 · see citing works

Serum Procalcitonin Levels in Patients with Primary Pulmonary Coccidioidomycosis

Sakata, K. K., Grys, T. E., Chang, Y.-H. H., Vikram, H. R., & Blair, J. E. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201404-180bc · Cited by 10 · see citing works

The role of immune and metabolic biomarkers for improved management of sepsis patients

Schüetz, P., & Müeller, B. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.932250 · Cited by 9 · see citing works

Procalcitonin for clinical decisions on influenza-like illness in emergency department during influenza a(H1N1)2009 pandemic

Canavaggio, P., Boutolleau, D., Goulet, H., Riou, B., & Hausfater, P. (2016) · Biomarkers · doi:10.1080/1354750x.2016.1276626 · Cited by 8 · see citing works

The role of bacterial vaccines in the prevention of influenza mortality

Klugman, K. P., Madhi, S. A., Ginsburg, A. S., & Rodgers, G. L. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30445-5 · Cited by 7 · see citing works

Outcome prediction using the Mortality in Emergency Department Sepsis score combined with procalcitonin for influenza patients

Teng, F., Wan, T., Guo, S., Liu, X., Cai, J.-F., Qi, X., & Liu, W.-X. (2019) · Medicina Clínica · doi:10.1016/j.medcli.2019.03.021 · Cited by 8 · see citing works

Procalcitonin as a biomarker of nosocomial pneumonia in aneurysmal subarachnoid hemorrhage patients treated in neuro-ICU

Wang, R., Zhang, J., He, M., Chen, H., & Xu, J. (2023) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2023.107870 · Cited by 7 · see citing works

Updates in the management of respiratory virus infections in ICU patients: revisiting the non-SARS-CoV-2 pathogens

Saura, O., Chommeloux, J., Levy, D. E., Assouline, B., Lefèvre, L., & Luyt, C. E. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2134116 · Cited by 7 · see citing works

Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower respiratory tract infections in Argentina

Garay, O. U., Guiñazú, G. G., Cornistein, W., Farina, J., Valentini, R. N., & Hara, G. L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250711 · Cited by 6 · see citing works

Management of Severe Influenza

O’Driscoll, L. S., & Martín‐Loeches, I. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1735491 · Cited by 6 · see citing works

Influenza Virus

Hayden, F. G., & Palese, P. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch43 · Cited by 6 · see citing works

Procalcitonin as a biomarker to guide treatments for patients with lower respiratory tract infections

Saura, O., & Luyt, C. E. (2023) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2023.2251394 · Cited by 6 · see citing works

Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections—The Fluco French cohort

Ploin, D., Chidiac, C., Carrat, F., Cohen, B., Javouhey, É., Mayaud, C. M., Desenclos, J. C., Lina, B., & Leport, C. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.05.025 · Cited by 6 · see citing works

Severe Bacterial Superinfection of Influenza Pneumonia in Immunocompetent Young Patients: Case Reports

Białka, S., Zieliński, M., Latos, M., Skurzyńska, M., Żak, M., Palaczyński, P., & Skoczyński, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195665 · Cited by 5 · see citing works

Prediction of influenza virus infection based on deep learning and peripheral blood proteomics: A diagnostic study

Zhou, Y., Wang, P., Zhang, H., Wang, T., Han, S., Ma, X., Liang, S., Bai, M.-H., Fan, P., Wang, L., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.03.051 · Cited by 5 · see citing works

Prevalence of early bacterial co-infection in hospitalized patients with COVID-19 pneumonia: a retrospective study

Satjawattanavimol, S., Teerapuncharoen, K., Kaewlai, R., & Disayabutr, S. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-22-1681 · Cited by 4 · see citing works

Outcome prediction using the Mortality in Emergency Department Sepsis score combined with procalcitonin for influenza patients

Teng, F., Wan, T., Guo, S., Liu, X., Cai, J.-F., Qi, X., & Liu, W.-X. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.03.022 · Cited by 4 · see citing works

Diagnostic value of procalcitonin for identifying the etiology of lower respiratory tract infections: a systematic review and meta-analysis

Lin, C., Zhou, X. C., Li, G., Qiu, J., Li, D., & Pang, Q.-Y. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12426-9 · Cited by 3 · see citing works

Formes graves de la grippe H1N1 2009 chez l’adulte: l’expérience française

Reva-Grippe-SRLF, P. L. R., Mercat, A., Pham, T. O., Rozé, H., Cuquemelle, É., Brun‐Buisson, C., Brochard, L. J., & Richard, J.-C. (2011) · Réanimation · doi:10.1007/s13546-011-0266-7 · Cited by 3 · see citing works

Diagnostic Accuracy of Procalcitonin upon Emergency Department Admission during SARS-CoV-2 Pandemic

Malinverni, S., Lazzaroni, S., Nuňez, M., Préseau, T., COTTON, F. J., Martiny, D., Bouazza, F.-Z., Collot, V., Konopnicki, D., Alard, S., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11091141 · Cited by 3 · see citing works

The bacterial pneumonias: a new treatment paradigm

Marik, P. E. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1001708 · Cited by 3 · see citing works

Low Levels of Procalcitonin Are Related to Decreased Antibiotic Use in Children Hospitalized Due to Influenza

Wrotek, A., Wrotek, O., & Jackowska, T. (2022) · Diagnostics · doi:10.3390/diagnostics12051148 · Cited by 3 · see citing works

Antimicrobial Therapy and COVID-19 — the 'Great Confrontation'

Zaytsev, A. A., & Михайлович, М. А. (2022) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2022-67-9-10-63-68 · Cited by 2 · see citing works

The Role of Procalcitonin in Respiratory Infections

Certain, L., & Schüetz, P. (2012) · Current Infectious Disease Reports · doi:10.1007/s11908-012-0249-5 · Cited by 2 · see citing works

Should procalcitonin be used as a routine biomarker of bacterial infection?

Das, R. R. (2012) · Infection · doi:10.1007/s15010-012-0253-6 · Cited by 2 · see citing works

The Role of Procalcitonin as an Antimicrobial Stewardship Tool in Patients Hospitalized with Seasonal Influenza

Christensen, I. R., Berild, D., Bjørnholt, J. V., Jelsness‐Jørgensen, L., Debes, S., & Haug, J. B. (2023) · Antibiotics · doi:10.3390/antibiotics12030573 · Cited by 1 · see citing works

Infectious Disease Biomarkers: Non-Antibody-Based Host Responses

Schuetz, A. N. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3970-7_7 · Cited by 1 · see citing works

The Value of Procalcitonin in CAP Remains Unclear

Wunderink, R. G., WATERER, G. W., & Rello, J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.184.10.1210a · Cited by 1 · see citing works

The Significance of Procalcitonin and C-Reactive Protein in Diagnostic Tests for Respiratory Adenovirus Infections in Children

Kunze, W., Klemm, T., & Streidl, J.-P. (2015) · OALib · doi:10.4236/oalib.1101717

Infection virale sévère et surinfection bronchique chez une femme obèse

Cuquemelle, É. (2013) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(13)70348-3

Biomarkers in Inflammation

Kortgen, A., & Bauer, M. W. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch61

Serum procalcitonin as a biomarker for differentiation of both radiation pneumonitis and chemotherapy induced pneumonitis from bacterial pneumonia

강효재 (2014)

Combined use of procalcitonin and C-reactive protein levels can help clinically diagnose bacterial co-infections in children infected with H1N1 influenzaPreprint

Li, Z., He, L., Li, S., He, W., Zha, C., Hou, Q., Wang, W., Sun, X., Liang, H., & Ou, W. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/318063

Incidence and Characteristics of Co-infection and Secondary Infection in Patients with COVID-19Preprint

Guo, Y., Qu, J., Cheng, L., Li, X., Liu, N., Li, T., Jiang, Y., Wan, Q., Zhuo, C., Xiao, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.06.425542

Do the Rapid Influenza Diagnostic Tests Results Reflect the Truth?

Yalçın, T. Y., Erol, Ç., Aydın, S., Sarı, N., Azap, Ö. K., & Arslan, H. (2021) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2021.74755

Procalcitonin

Schüetz, P., & Leykum, L. K. (2012) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2012.04.005

Challenges in Severe Influenza Pneumonia

Vallecoccia, M. S., Murphy, O. A., Rodríguez, A. H., & Martín‐Loeches, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11489-8

Can Procalcitonin help to distinguish between an acute bacterial pneumonia and influenza A (H1N1) pneumonia on an intensive care unit?

Pfister, R., Kochanek, M., Leygeber, T., Brun‐Buisson, C., Cuquemelle, É., Machado, M. B. P., Piacentini, E., Hammond, N. E., Ingram, P. R., & Michels, G. (2014) · Pneumologie · doi:10.1055/s-0034-1367795

Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis

Pfister, R., Kochanek, M., Leygeber, T., Brun‐Buisson, C., Cuquemelle, É., Machado, M. P., Piacentini, E. A., Hammond, N. E., Ingram, P. R., & Michels, G. (2014) · Critical Care · doi:10.1186/cc13760 · Cited by 105 · see citing works

Procalcitonin in 2009 H1N1 Influenza Pneumonia: Role in Differentiating from Bacterial Pneumonia

Ahn, S., Kim, W., Yoon, J. Y., Sohn, C. H., Seo, D. W., Kim, S., Hong, S. B., Lim, C. M., Koh, Y. S., & Kim, W. B. (2010) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2010.68.4.205 · Cited by 4 · see citing works

Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia: Mixed bacterial infection in 2009 H1N1 influenza

Ahn, S., Kim, W. Y., Kim, S.-H., Hong, S., Lim, C.-M., Koh, Y., Lim, K. S., & Kim, W. (2011) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00244.x · Cited by 64 · see citing works

Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection

Ingram, P. R., Inglis, T. J. J., Moxon, D., & Speers, D. J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1746-3 · Cited by 102 · see citing works